CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Transcutaneous Vagal Nerve Stimulation (tVNS)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04484285
NCT04484285N/ACompleted
CompareCT.gov

Home Operations Utilizing Stimulation

University of Florida·interventional·Posted Jul 23, 2020·Updated Apr 20, 2025

In Brief

A clinical study evaluating Transcutaneous Vagal Nerve Stimulation (tVNS) for Cognitive Performance. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This project will utilize a home-operated stimulator in 1) a healthy young adult population and 2) a healthy older adult population to provide a proof of concept of home-use of transcutaneous vagal nerve stimulation (tVNS). tVNS is believed to modulate cognitive performance.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCognitive Performance
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJul 23, 2020
Enrollment StartAug 20, 2020
Primary CompletionSep 6, 2023
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 5.9 years ago

Interventions

Transcutaneous Vagal Nerve Stimulation (tVNS)device

vagal nerve stimulation